Chronic Non-cirrhotic Portal Vein Thrombosis with Cavernous Transformation Secondary to Protein C and S Deficiency

被引:4
作者
Majid, Zainab [1 ]
Tahir, Faryal [1 ]
Bin Arif, Taha [1 ]
Ahmed, Jawed [1 ]
机构
[1] Dow Univ Hlth Sci, Internal Med, Karachi, Pakistan
关键词
hereditary thrombophilias; portal vein thrombosis; protein s deficiency; splenorenal shunt; splenectomy; protein c deficiency; cavernous transformation of the portal vein; anticoagulant therapy; RISK;
D O I
10.7759/cureus.7142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary thrombophilia (HT), including the mutation of factor V gene and the deficiency of proteins C, protein S, or antithrombin, is a risk factor for portal vein thrombosis (PVT). PVT in acute cases is usually asymptomatic, whereas chronic cases mostly present as variceal bleeding and splenomegaly. However, cavernous transformation of the portal vein secondary to a long-standing PVT is very rare. Here we present a case of a 28-year-old female who was admitted with complaints of left upper abdominal pain and swelling for four to five years. Using laboratory and radiological examinations, a confirmatory diagnosis of cavernous transformation of a thrombosed portal vein due to protein C and S deficiency was made. The patient was managed through splenectomy with splenorenal shunting along with life-long prescription of anticoagulants.
引用
收藏
页数:10
相关论文
共 15 条
  • [1] [Anonymous], 2017, PORTAL VEIN OBSTRUCT
  • [2] Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
    Condat, B
    Pessione, F
    Hillaire, S
    Denninger, MH
    Guillin, MC
    Poliquin, M
    Hadengue, A
    Erlinger, S
    Valla, D
    [J]. GASTROENTEROLOGY, 2001, 120 (02) : 490 - 497
  • [3] Screening tests for thrombophilic patients: Which tests, for which patient, by whom, when, and why?
    De Moerloose, P
    Bounameaux, HR
    Mannucci, PM
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1998, 24 (04) : 321 - 327
  • [4] Portal vein thrombosis in liver cirrhosis
    Fimognari, Filippo Luca
    Violi, Francesco
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2008, 3 (03) : 213 - 218
  • [5] Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?
    Fisher, NC
    Wilde, JT
    Roper, J
    Elias, E
    [J]. GUT, 2000, 46 (04) : 534 - 539
  • [6] GILL SS, 1975, ARCH SURG-CHICAGO, V110, P254
  • [7] Portal hypertension due to portal venous thrombosis: Etiology, clinical outcomes
    Harmanci, Ozgur
    Bayraktar, Yusuf
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (18) : 2535 - 2540
  • [8] Ögren M, 2006, WORLD J GASTROENTERO, V12, P2115
  • [9] Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-up Study
    Plessier, Aurelie
    Darwish-Murad, Sarwa
    Hernandez-Guerra, Manuel
    Consigny, Yann
    Fabris, Federica
    Trebicka, Jonel
    Heller, Jorg
    Morard, Isabelle
    Lasser, Luc
    Langlet, Philippe
    Denninger, Marie-Helene
    Vidaud, Dominique
    Condat, Bertrand
    Hadengue, Antoine
    Primignani, Massimo
    Garcia-Pagan, Juan-Carlos
    Janssen, Harry L. A.
    Valla, Dominique
    [J]. HEPATOLOGY, 2010, 51 (01) : 210 - 218
  • [10] Quarrie Ricardo, 2018, Int J Crit Illn Inj Sci, V8, P73, DOI 10.4103/IJCIIS.IJCIIS_71_17